These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9667278)
21. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors. Rowinsky EK; Noe DA; Trump DL; Winer EP; Lucas VS; Wargin WA; Hohneker JA; Lubejko B; Sartorius SE; Ettinger DS J Clin Oncol; 1994 Sep; 12(9):1754-63. PubMed ID: 8083697 [TBL] [Abstract][Full Text] [Related]
22. Oral versus intravenous vinorelbine: clinical safety profile. Gebbia V; Puozzo C Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453 [TBL] [Abstract][Full Text] [Related]
23. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
24. [Variability of the bioavailability of cyclosporine: benefit of the Neoral formulation]. Humbert H Therapie; 1997; 52(4):353-7. PubMed ID: 9437891 [TBL] [Abstract][Full Text] [Related]
25. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells. Patil S; Choudhary B; Rathore A; Roy K; Mahadik K Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533 [TBL] [Abstract][Full Text] [Related]
26. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325 [TBL] [Abstract][Full Text] [Related]
27. Formulations for pulmonary administration of anticancer agents to treat lung malignancies. Carvalho TC; Carvalho SR; McConville JT J Aerosol Med Pulm Drug Deliv; 2011 Apr; 24(2):61-80. PubMed ID: 21410326 [TBL] [Abstract][Full Text] [Related]
28. Capecitabine: a review. Walko CM; Lindley C Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604 [TBL] [Abstract][Full Text] [Related]
29. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. Wu Y; Loper A; Landis E; Hettrick L; Novak L; Lynn K; Chen C; Thompson K; Higgins R; Batra U; Shelukar S; Kwei G; Storey D Int J Pharm; 2004 Nov; 285(1-2):135-46. PubMed ID: 15488686 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase. Baker SD; Khor SP; Adjei AA; Doucette M; Spector T; Donehower RC; Grochow LB; Sartorius SE; Noe DA; Hohneker JA; Rowinsky EK J Clin Oncol; 1996 Dec; 14(12):3085-96. PubMed ID: 8955653 [TBL] [Abstract][Full Text] [Related]
31. Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors. Zamboni WC; Bowman LC; Tan M; Santana VM; Houghton PJ; Meyer WH; Pratt CB; Heideman RL; Gajjar AJ; Pappo AS; Stewart CF Cancer Chemother Pharmacol; 1999; 43(6):454-60. PubMed ID: 10321504 [TBL] [Abstract][Full Text] [Related]
32. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics. Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915 [TBL] [Abstract][Full Text] [Related]
33. High plasma levels and effective lymphatic uptake of docetaxel in an orally available nanotransporter formulation. Nassar T; Attili-Qadri S; Harush-Frenkel O; Farber S; Lecht S; Lazarovici P; Benita S Cancer Res; 2011 Apr; 71(8):3018-28. PubMed ID: 21363913 [TBL] [Abstract][Full Text] [Related]
34. Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093). Kuppens IE; Bosch TM; van Maanen MJ; Rosing H; Fitzpatrick A; Beijnen JH; Schellens JH Cancer Chemother Pharmacol; 2005 Jan; 55(1):72-8. PubMed ID: 15316750 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas. Kroschinsky FP; Friedrichsen K; Mueller J; Pursche S; Haenel M; Prondzinsky R; Ehninger G; Schleyer E Cancer Chemother Pharmacol; 2008 Apr; 61(5):785-90. PubMed ID: 17579865 [TBL] [Abstract][Full Text] [Related]
36. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs. Lam MS Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer. Skirvin JA; Lichtman SM Drugs Aging; 2002; 19(1):25-42. PubMed ID: 11929325 [TBL] [Abstract][Full Text] [Related]
38. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel. Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332 [TBL] [Abstract][Full Text] [Related]
39. P-glycoprotein and bioavailability-implication of polymorphism. Liu Y; Hu M Clin Chem Lab Med; 2000 Sep; 38(9):877-81. PubMed ID: 11097343 [TBL] [Abstract][Full Text] [Related]
40. Oral efficacy and bioavailability of a novel taxane. Polizzi D; Pratesi G; Monestiroli S; Tortoreto M; Zunino F; Bombardelli E; Riva A; Morazzoni P; Colombo T; D'Incalci M; Zucchetti M Clin Cancer Res; 2000 May; 6(5):2070-4. PubMed ID: 10815934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]